Final Results for the year ended 30 June 2014

Chairman’s Statement

 

Summary of Results in the year ended 30 June 2014

 

  • The turnover of the Company increased by 12% to £267,903 (2013: £240,000).
  • The operating loss reduced by 15% to £465,265 (2013: £548,342).
  • On 30 June 2014 the surplus of shareholders’ funds was £136,487 (2013: £255,821).

This year, Physiomics has made good progress advancing Virtual Tumour Clinical and has broadened its offering into the personalised medicine market.

In summary we have...Read more

})(jQuery)